Clinical trial
Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar…
NCT00015769 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00015769 |
|---|---|
| Title | Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness |
| Official title | Pilot Evaluation of Levetiracetam (Keppra® (Registered Trademark)) in Bipolar Illness |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | levetiracetam |
| Enrollment | 30 |
| Start date | Apr 1, 2001 |
| Completion | Apr 1, 2003 |
| First posted | May 7, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: